M&A Deal Summary

Norgine and SpePharm Holding B.V. Acquire Spepharm Ag

On January 1, 2012, Norgine and SpePharm Holding B.V. acquired life science company Spepharm Ag

Acquisition Highlights
  • This is Norgine’s 2nd and SpePharm Holding B.V.’s 1st transaction in the Life Science sector.
  • This is Norgine’s 1st and SpePharm Holding B.V.’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2012-01-01
Target Spepharm Ag
Sector Life Science
Buyer(s) Norgine
SpePharm Holding B.V.
Deal Type Joint Venture

Target

Spepharm Ag

Switzerland
SpePharm AG commercialize SpePharm’s Specialty Pharmaceutical products through Norgine’s European infrastructure.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Norgine

Amsterdam, Netherlands

Category Company
Founded 1906
Sector Life Science
DESCRIPTION

Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.


DEAL STATS #
Overall 2 of 5
Sector (Life Science) 2 of 4
Type (Joint Venture) 1 of 1
Country (Switzerland) 1 of 1
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-26 Alizyme - cetilistat

United Kingdom

Alizyme - cetilistat is a drug designed to treat obesity.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Endocuff

Leeds, United Kingdom

ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom.

Buy -
Buyer

SpePharm Holding B.V.

Amsterdam, Netherlands

Category Company
Founded 2006
Sector Life Science
DESCRIPTION

SpePharm Holding B.V. is a specialty pharmaceutical company, engages in acquiring, registering, and marketing specialty medicines, essentially for the hospital market.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Joint Venture) 1 of 1
Country (Switzerland) 1 of 1
Year (2012) 1 of 1